絞り込み

16403

広告

Tandem mass spectrometry assay of β-glucocerebrosidase activity in dried blood spots eliminates false positives detected in fluorescence assay.

著者 Wolf P , Alcalay RN , Liong C , Cullen E , Pauciulo MW , Nichols WC , Gan-Or Z , Chung WK , Faulkner T , Bentis C , Pomponio RJ , Ma X , Kate Zhang X , Keutzer JM , Oliva P
Mol Genet Metab.2017 Oct 23 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (17view , 0users)

Full Text Sources

Miscellaneous

Deficiency of β-Glucocerebrosidase (GBA) activity causes Gaucher Disease (GD). GD can be diagnosed by measuring GBA activity (Beutler and Kuhl, 1990). In this study, we assayed dried blood spots from a cohort (n=528) enriched for GBA mutation carriers (n=78) and GD patients (n=18) using both the tandem mass spectrometry (MS/MS) and fluorescence assays and their respective synthetic substrates. The MS/MS assay differentiated normal controls, which included GBA mutation carriers, from GD patients with no overlap. The fluorescence assay did not always differentiate normal controls including GBA mutation carriers from GD patients and false positives were observed. The MS/MS assay improved specificity compared to the fluorescence assay.
PMID: 29100779 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード